Johnson & Johnson Articles
Expanded indication for Velcade in EU
9 May 2005
M&A: managing the "honeymoon blues"
9 May 2005
Chemicals see Zeltia's 1st-qtr losses double
9 May 2005
Millennium Pharma and J&J advance Velcade trials
28 April 2005
Together Rx Access ads launched
27 April 2005
J&J's 17% 1st-qtr earnings rise beats analysts' expectations; firm to buy Peninsula Pharma
25 April 2005
1st-qtr net doubles for Akzo Nobel
25 April 2005
J&J completes $230M acquisition of TransForm Pharma
11 April 2005
Stock Commentary - New York
11 April 2005
Zeltia's Yondelis enters Phase III
11 April 2005
Organon/J&J end Risperdal co-promotion
11 April 2005
FDA seeks more trials for Biovail's pain drug
11 April 2005
Ex-rep's movie "exposes Rx marketing practices"
28 March 2005
Johnson & Johnson to acquire TransForm Pharmaceuticals
21 March 2005
J&J's Cypher stent not superior to BS' Taxus
14 March 2005
Millennium gets $40.0M milestones
14 March 2005
Johnson & Johnson buys CLOSURE Medical in $370M deal
14 March 2005
GenVec starts Ph IIb trial of Biobypass
14 March 2005
UK NICE seeks to curb Alzheimer's drugs
7 March 2005
Drugs from Europe "safer than getting them in the USA," Pfizer VP tells US Senate hearing
28 February 2005
Zeltia rejects rumors on PharmaMar bid
21 February 2005
SAFE biopharma digital identity standard move
21 February 2005
Accelerated US approval for Ortho Biotech's Doxil
14 February 2005
Eon Labs starts shipping generic itraconazole in USA
14 February 2005
Richter Gedeon sales earnings up 11.7% in difficult 2004
14 February 2005
Hitch for Pennsylvania drug pricing suit
14 February 2005
PDL adjusts price for ESP Pharma
14 February 2005
Editor's views on US profit repatriation, re-importation
7 February 2005
Abbott's RA drug Humira a potential therapy for Crohn's disease?
7 February 2005
Japan stock market week to January 31
7 February 2005
Mylan's pain patch gets FDA clearance
7 February 2005
J&JPRD completes Zarnestra NDA
7 February 2005
J&J's 4th-qtr net earnings plunge 34%
31 January 2005
Addex and Ortho-McNeil in research deal
24 January 2005
J&J names Christine Poon vice chairman
24 January 2005
Highlights of pharmaceutical mergers and acquisitions in 2004
24 January 2005
Lilly, J&J plan profits repatriation
24 January 2005
FDA panel rejects Merck & Co/J&J's application for OTC Mevacor
24 January 2005
Amgen adds safety warning to Aranesp
24 January 2005
Euro advanced wound- healing market set to grow 12.4%/year
24 January 2005
Biogenerics to command more than $12B by 2010
17 January 2005
Millennium and J&J start Velcade Ph III study
17 January 2005
J&J uses Elan technology for paliperidone trial
17 January 2005
Industry cuts 275+ Rx prices for US uninsured under expanded Together Rx Access plan
17 January 2005
Alkermes expands Risperdal Consta capacity
17 January 2005
Japan stock market week to January 10
17 January 2005
Sunesis extends collaboration with J&J
17 January 2005
Infinity in small molecule alliance with J&J
10 January 2005
Bristol-Myers Squibb in talks to sell analgesics business?
10 January 2005
Japan stock market three weeks to January 3
10 January 2005
Neurochem and J&J enter Fibrillex alliance
10 January 2005
MorphoSys expands accord with Centocor
10 January 2005
Global collaboration for Arena and Ortho-McNeil
10 January 2005
454 Life Sciences assists new drug for TB study
10 January 2005
Lilly adds liver warning to Strattera label
10 January 2005
FDA fast-track for J&J/S-P's Remicade
10 January 2005
J&J to buy Guidant in $25.4 billion deal
20 December 2004
Stock Commentary - New York
20 December 2004
J&J's antibiotic offers hope against TB
20 December 2004
US sales decline hits Santen results
22 November 2004
Long-term use of Reminyl beneficial
15 November 2004
George Schreiner joins Scios as president, research and development
15 November 2004
Daiichi sees first-half revenues fall 2%
15 November 2004
Pain compound deal for Enhance and Alza
8 November 2004
Millennium's Velcade on FDA fast-track for new use
8 November 2004
Stock Commentary - New York
25 October 2004
Alltracel employs Neil Luckianow as head of US sales operations
11 October 2004
Cephalon appoints Elizabeth Mutisya VP medical affairs and promotes Robert Hrubiec
20 September 2004
Appointments at Schering-Plough Research Institute
20 September 2004
Innovative drugs and their impact on the future of oncology developments
20 September 2004
Menarini's nebivolol shows benefit in elderly heart failure patients; SENIORS study
13 September 2004
Milestone for Icagen from McNeil
6 September 2004
Stock Commentary - New York
6 September 2004
J&J France to acquire Biapharm
6 September 2004
US pharma election spend: "$870,000+ for Bush"
6 September 2004
Othera raises $13M in a Series B financing
6 September 2004
FDA and Centocor issue Remicade warning
30 August 2004
Centocor extends license to MorphoSys' antibody
30 August 2004
Chromos and Centocor in cell line deal
30 August 2004
Israel: complaints over funds' drug access
23 August 2004
Daiichi Pharma
23 August 2004
UK for J&J's epilepsy drug Topamax in migraine
23 August 2004
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
